(RTTNews) - A billion-dollar deal was announced by a major pharmaceutical company today, sending a wave of optimism across the RNA therapeutics space. Avidity Biosciences Inc. (RNA) is all set to be ...
Aligned with FDA on del-brax accelerated and full approval pathways for FSHD, reported positive topline data from Phase 1/2 FORTITUDE™ trial, and initiated global confirmatory Phase 3 study Planned ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback